Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Wells Fargo analysts reiterated a Overweight rating on Caterpillar Inc. (NYSE:CAT) on June 23, 2026. Market Context Caterpillar Inc.
Read moreRating Change JP Morgan analysts upgraded International Business Machines Corporation (NYSE:IBM) from Neutral to Overweight on June 23, 2026. Market Context International Business…
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on International Business Machines Corporation (NYSE:IBM) on June 23, 2026. Market Context International…
Read moreRating Change B of A Securities analysts reiterated a Buy rating on Applied Materials, Inc. (NASDAQ:AMAT) on June 23, 2026. Market Context Applied Materials, Inc.
Read moreRating Change Wolfe Research analysts downgraded The Home Depot, Inc. (NYSE:HD) from Outperform to Peer Perform on June 23, 2026. Market Context The Home Depot, Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on Bank of America Corporation (NYSE:BAC) on June 23, 2026. Market Context Bank of America Corporation operates in the…
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on AbbVie Inc. (NYSE:ABBV) on June 23, 2026. Market Context AbbVie Inc.
Read moreRating Change Piper Sandler analysts reiterated a Overweight rating on AbbVie Inc. (NYSE:ABBV) on June 23, 2026. Market Context AbbVie Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on Bank of America Corporation PFD SER B 7% (OTC:BACRP) on June 23, 2026. Market Context Bank of America Corporation PFD…
Read moreRating Change Litchfield Hills analysts initiated coverage on NextPlat Corp (NASDAQ:NXPL) with a Buy rating on June 24, 2026. Market Context NextPlat Corp operates in the…
Read moreRating Change Barclays analysts initiated coverage on SAB Biotherapeutics, Inc. (NASDAQ:SABS) with a Overweight rating on June 24, 2026. Market Context SAB Biotherapeutics, Inc.
Read moreRating Change Citigroup analysts reiterated a Neutral rating on Ecovyst Inc. (NYSE:ECVT) on June 24, 2026. Market Context Ecovyst Inc.
Read moreRating Change Evercore ISI Group analysts initiated coverage on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) with a Outperform rating on June 24, 2026. Market Context PROCEPT…
Read moreRating Change Barclays analysts reiterated a Overweight rating on 10x Genomics, Inc. (NASDAQ:TXG) on June 24, 2026. Market Context 10x Genomics, Inc.
Read moreRating Change Stifel analysts reiterated a Buy rating on Power Integrations, Inc. (NASDAQ:POWI) on June 24, 2026. Market Context Power Integrations, Inc.
Read moreRating Change Morgan Stanley analysts reiterated a Overweight rating on ACM Research, Inc. (NASDAQ:ACMR) on June 24, 2026. Market Context ACM Research, Inc.
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on Northern Trust Corporation (NASDAQ:NTRSO) on June 24, 2026. Market Context Northern Trust Corporation…
Read moreRating Change Stephens & Co. analysts upgraded Varonis Systems, Inc. (NASDAQ:VRNS) from Equal-Weight to Overweight on June 24, 2026.
Read moreRating Change Wedbush analysts reiterated a Outperform rating on Varonis Systems, Inc. (NASDAQ:VRNS) on June 24, 2026. Market Context Varonis Systems, Inc.
Read moreRating Change Mizuho analysts downgraded Apogee Therapeutics, Inc. (NASDAQ:APGE) from Outperform to Neutral on June 24, 2026. Market Context Apogee Therapeutics, Inc.
Read more
